Carmen Mora-Fernández - 著者 - Inventaire

Carmen Mora-Fernández

出身校: Facultad de Medicina (Universidad de Alcalá)

職業: 研究者

シリーズ

There is nothing here

Create a new serie

作品

There is nothing here

Create a new work

記事 60

Date

タイトル

著者

2020-02-07

Inflammatory Targets in Diabetic Nephropathy

Juan F Navarro-González, Carmen Mora-Fernández
2020-01-27

Association between serum levels of Klotho and inflammatory cytokines in cardiovascular disease: a case-control study

Juan F Navarro-González, Carmen Mora-Fernández
2019-02-27

Pentoxifylline for Renal Protection in Diabetic Kidney Disease. A Model of Old Drugs for New Horizons

Javier Donate-Correa, Víctor G Tagua, Carmen Mora-Fernández
2019-04-03

FGF23 and Klotho Levels are Independently Associated with Diabetic Foot Syndrome in Type 2 Diabetes Mellitus

Javier Donate-Correa, Víctor G Tagua, Juan F Navarro-González, Ernesto Martín-Núñez, Carla Ferri, Sergio T Rodríguez, Carmen Mora-Fernández
2019-09-22

Fibroblast growth factor 23 expression in human calcified vascular tissues

Javier Donate-Correa, Víctor G Tagua, Juan F Navarro-González, Carmen Mora-Fernández
2018-10-01

Inflammation in Diabetic Kidney Disease

Jose M Valdivielso, Alberto Ortiz, Carmen Mora-Fernández
2018-06-04

Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease

Juan F Navarro-González, Maria Dolores Sanchez-niño, Javier Donate-Correa, Carmen Mora-Fernández
2017-10-25

Soluble levels and endogenous vascular gene expression of KLOTHO are related to inflammation in human atherosclerotic disease

Sergio T Rodríguez, Juan F Navarro-González, Carmen Mora-Fernández
2017-06-15

Anti-inflammatory profile of paricalcitol in kidney transplant recipients

Javier Donate-Correa, Juan F Navarro-González, Carmen Mora-Fernández
2016-11-01

Effect of Paricalcitol on FGF-23 and Klotho in Kidney Transplant Recipients

Carmen Mora-Fernández, Juan F Navarro-González
2015-11-26

Klotho in cardiovascular disease: Current and future perspectives

Javier Donate-Correa, Carmen Mora-Fernández, Juan F Navarro-González
2015-02-15

Inflammatory cytokines in diabetic nephropathy

Javier Donate-Correa, Carmen Mora-Fernández, Juan F Navarro-González
2015-11-05

Influence of Klotho gene polymorphisms on vascular gene expression and its relationship to cardiovascular disease

Javier Donate-Correa, Carmen Mora-Fernández, Juan F Navarro-González
2015-12-10

Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetes

Carmen Mora-Fernández, Javier Donate-Correa, Alberto Ortiz
2014-09-15

Diabetic kidney disease: from physiology to therapeutics

Carmen Mora-Fernández, Juan F Navarro-González
2014-12-01

Implications of Klotho in vascular health and disease

Javier Donate-Correa, Carmen Mora-Fernández, Juan F Navarro-González
2014-06-26

Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial

Juan F Navarro-González, Carmen Mora-Fernández
2014-01-06

Selective vitamin D receptor activation as anti-inflammatory target in chronic kidney disease

Javier Donate-Correa, Carmen Mora-Fernández, Juan F Navarro-González
2014-01-01

Beneficial effects of selective vitamin D receptor activation by paricalcitol in chronic kidney disease

Javier Donate-Correa, Carmen Mora-Fernández, Juan F Navarro-González
2013-02-20

Anti-inflammatory profile of paricalcitol in hemodialysis patients: a prospective, open-label, pilot study

Juan F Navarro-González, Javier Donate-Correa, Carmen Mora-Fernández
2013-01-18

Fibroblast growth factor 23/Klotho system in the context of cardiovascular damage

Javier Donate-Correa, Carmen Mora-Fernández, Juan F Navarro-González
2013-10-28

Reduced Klotho is associated with the presence and severity of coronary artery disease

Juan F Navarro-González, Javier Donate-Correa, Carmen Mora-Fernández
2012-02-22

FGF23/Klotho axis: phosphorus, mineral metabolism and beyond

Javier Donate-Correa, Carmen Mora-Fernández, Juan F Navarro-González
2011-05-03

Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy

Juan F Navarro-González, Carmen Mora-Fernández
2011-06-09

Inflammatory pathways

Juan F Navarro-González, Carmen Mora-Fernández
2011-09-25

Expression of FGF23/KLOTHO system in human vascular tissue

Javier Donate-Correa, Carmen Mora-Fernández, Juan F Navarro-González
2010-03-16

Erdheim-Chester disease as cause of end-stage renal failure: a case report and review of the literature

Carmen Mora-Fernández
2010-12-08

Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results

Juan F Navarro-González, Carmen Mora-Fernández
2010-01-01

Serum and gene expression profile of tumor necrosis factor-alpha and interleukin-6 in hypertensive diabetic patients: effect of amlodipine administration

Carmen Mora-Fernández
2009-09-24

Mineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study

Juan F Navarro-González, Carmen Mora-Fernández
2009-03-01

Pathogenic perspectives for the role of inflammation in diabetic nephropathy

Juan F Navarro-González, Carmen Mora-Fernández
2009-02-28

Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy

Juan F Navarro-González, Carmen Mora-Fernández

Human - wd:Q54237845

Welcome to Inventaire

友達やコミュニティの図書館

もっと調べる

you are offline